129 related articles for article (PubMed ID: 26958146)
1. Middle Cerebral Artery Occlusion Model of Stroke in Rodents: A Step-by-Step Approach.
Shahjouei S; Cai PY; Ansari S; Sharififar S; Azari H; Ganji S; Zand R
J Vasc Interv Neurol; 2016 Jan; 8(5):1-8. PubMed ID: 26958146
[TBL] [Abstract][Full Text] [Related]
2. Surgical Approach for Middle Cerebral Artery Occlusion and Reperfusion Induced Stroke in Mice.
Vital SA; Gavins FN
J Vis Exp; 2016 Oct; (116):. PubMed ID: 27805602
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
Yu S; Liu X; Shen Y; Xu H; Yang Y; Ding F
Neuroscience; 2016 Jul; 327():44-52. PubMed ID: 27060484
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
5. Middle Cerebral Artery Occlusion Allowing Reperfusion via Common Carotid Artery Repair in Mice.
Trotman-Lucas M; Kelly ME; Janus J; Gibson CL
J Vis Exp; 2019 Jan; (143):. PubMed ID: 30735149
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models.
Karatas H; Eun Jung J; Lo EH; van Leyen K
Brain Res; 2018 Jan; 1678():123-128. PubMed ID: 29079502
[TBL] [Abstract][Full Text] [Related]
7. Modeling Transient Focal Ischemic Stroke in Rodents by Intraluminal Filament Method of Middle Cerebral Artery Occlusion.
Lopez MS; Vemuganti R
Methods Mol Biol; 2018; 1717():101-113. PubMed ID: 29468587
[TBL] [Abstract][Full Text] [Related]
8. A new middle cerebral artery occlusion model for intra-arterial drug infusion in rats.
Sun WH; Chen HS
Neurosci Lett; 2015 Oct; 607():102-107. PubMed ID: 26399437
[TBL] [Abstract][Full Text] [Related]
9. Neurobehavioural deficits correlate with the cerebral infarction volume of stroke animals: a comparative study on ischaemia-reperfusion and photothrombosis models.
Choi BI; Park D; Lee SH; Bae DK; Yang G; Yang YH; Kim TK; Choi EK; Lee HJ; Choi KC; Nahm SS; Kim YB
Environ Toxicol Pharmacol; 2012 Jan; 33(1):60-9. PubMed ID: 22134000
[TBL] [Abstract][Full Text] [Related]
10. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
[TBL] [Abstract][Full Text] [Related]
11. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
[TBL] [Abstract][Full Text] [Related]
13. Intraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities.
Khan IS; Odom M; Ehtesham M; Colvin D; Quarles CC; McLaughlin B; Singer RJ
J Neurosurg; 2016 Jul; 125(1):152-9. PubMed ID: 26544777
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats.
Li F; Omae T; Fisher M
Stroke; 1999 Nov; 30(11):2464-70; discussion 2470-1. PubMed ID: 10548685
[TBL] [Abstract][Full Text] [Related]
15. Treatment with tPA predicts better outcome even if MCA occlusion persists.
Kablau M; Alonso A; Hennerici MG; Fatar M
Int J Stroke; 2013 Oct; 8(7):496-502. PubMed ID: 22340025
[TBL] [Abstract][Full Text] [Related]
16. Ischemic stroke: experimental models and reality.
Sommer CJ
Acta Neuropathol; 2017 Feb; 133(2):245-261. PubMed ID: 28064357
[TBL] [Abstract][Full Text] [Related]
17. LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.
Niego B; Broughton BRS; Ho H; Sobey CG; Medcalf RL
Fluids Barriers CNS; 2017 Nov; 14(1):33. PubMed ID: 29157263
[TBL] [Abstract][Full Text] [Related]
18. Intranasal wnt3a Attenuates Neuronal Apoptosis through Frz1/PIWIL1a/FOXM1 Pathway in MCAO Rats.
Matei N; Camara J; McBride D; Camara R; Xu N; Tang J; Zhang JH
J Neurosci; 2018 Jul; 38(30):6787-6801. PubMed ID: 29954850
[TBL] [Abstract][Full Text] [Related]
19. A modification of intraluminal middle cerebral artery occlusion/reperfusion model for ischemic stroke with laser Doppler flowmetry guidance in mice.
Cai Q; Xu G; Liu J; Wang L; Deng G; Liu J; Chen Z
Neuropsychiatr Dis Treat; 2016; 12():2851-2858. PubMed ID: 27843320
[TBL] [Abstract][Full Text] [Related]
20. Clinical and vascular outcome in internal carotid artery versus middle cerebral artery occlusions after intravenous tissue plasminogen activator.
Linfante I; Llinas RH; Selim M; Chaves C; Kumar S; Parker RA; Caplan LR; Schlaug G
Stroke; 2002 Aug; 33(8):2066-71. PubMed ID: 12154264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
